Terrill K. McClanahan
- Immunology top 0.02%
- Psoriasis: Treatment and Pathogenesis 28
- T-cell and B-cell Immunology 16
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10
- IL-33, ST2, and ILC Pathways 9
- Immunodeficiency and Autoimmune Disorders 8
- Dermatology top 0.05%
- Dermatology and Skin Diseases 10
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 14
- Rheumatology top 0.2%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Wendy M. BlumenscheinJ. DanielRobert A. KasteleinYi ChenJeanine MattsonBeth BashamClaire L. LangrishRené de Waal Malefyt
- Cited by
- ImmunologyDermatologyOncology
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Terrill K. McClanahan
79 papers receiving 24.7k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 17.5k
- Dermatology 2.5k
- Oncology 7.3k
- Rheumatology 2.3k
- Pathology and Forensic Medicine 2.6k
Countries citing papers authored by Terrill K. McClanahan
This map shows the geographic impact of Terrill K. McClanahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terrill K. McClanahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terrill K. McClanahan more than expected).
Fields of papers citing papers by Terrill K. McClanahan
This network shows the impact of papers produced by Terrill K. McClanahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terrill K. McClanahan. The network helps show where Terrill K. McClanahan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Terrill K. McClanahan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 40 | |
| 2 | 2018 | 27 | |
| 3 | 2018 | 38 | |
| 4 | 2018 | 158 | |
| 5 | PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancerbreakdown → | 2017 | 453 |
| 6 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialbreakdown → | 2016 | 1275 |
| 7 | 2012 | 228 | |
| 8 | 2010 | 75 | |
| 9 | 2009 | 364 | |
| 10 | 2009 | 181 | |
| 11 | 2009 | 267 | |
| 12 | 2008 | 11 | |
| 13 | 2007 | 322 | |
| 14 | TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathologybreakdown → | 2007 | 1255 |
| 15 | 2006 | 184 | |
| 16 | 2006 | 304 | |
| 17 | WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27breakdown → | 2004 | 589 |
| 18 | Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammationbreakdown → | 2003 | 1327 |
| 19 | 1995 | 7 | |
| 20 | 1986 | 31 |
About Terrill K. McClanahan
Terrill K. McClanahan is a scholar working on Immunology, Dermatology and Oncology, having authored 82 papers that have together received 25.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (28 papers), T-cell and B-cell Immunology (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (11 papers), Dermatology and Skin Diseases (10 papers), Immune Cell Function and Interaction (10 papers), IL-33, ST2, and ILC Pathways (9 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). The work is most often cited by research in Immunology (17.5k citations), Dermatology (2.5k citations) and Oncology (7.3k citations). Terrill K. McClanahan has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Wendy M. Blumenschein, J. Daniel, Robert A. Kastelein, Yi Chen, Jeanine Mattson, Beth Basham, Claire L. Langrish, René de Waal Malefyt, Mandy J. McGeachy and Erin Murphy. Their work appears in journals such as Nature, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.